Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Preclinical animal anxiety research - flaws and prejudices.Reversal of social deficits by subchronic oxytocin in two autism mouse models.The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic MiceThe mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaAbnormal Motor Activity and Thermoregulation in a Schizophrenia Rat Model for Translational Science.Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice.Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor functionCysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler miceAnnual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.Nicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus.The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsIncreased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.Prepulse inhibition and genetic mouse models of schizophrenia.Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitementAtypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups.Short-term selective breeding for high and low prepulse inhibition of the acoustic startle response; pharmacological characterization and QTL mapping in the selected linesActivation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strengthDevelopment of a mouse test for repetitive, restricted behaviors: relevance to autism.Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.GluN1 hypomorph mice exhibit wide-ranging behavioral alterationsTargeting Neural Synchrony Deficits is Sufficient to Improve Cognition in a Schizophrenia-Related Neurodevelopmental Model.Treadmill exercise enhances NMDA receptor expression in schizophrenia mice.A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.Toxicological Effects of Aqueous Extract From African Walnut ( Tetracarpidium conophorum) Leaves in Rats.Prunella vulgaris attenuates prepulse inhibition deficit and attention disruption induced by MK-801 in mice.The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats.
P2860
Q24645703-C7F9BFF4-EF54-431E-AAD0-1D05F8928D73Q26749038-3945D2A3-DEE7-4FFE-BDB9-80D738474663Q28394708-5A9C5957-D53D-4D78-B2F6-4B3721FD2D47Q30362017-05B08154-80CD-44B5-ABDE-F6C4925B933AQ30364693-C7790C14-C614-4E0B-9B32-023DD3EC3392Q30371933-91ED890D-96E7-4BFB-92CA-99C8EFD203AEQ30396535-659F8053-1887-4FB8-BEC7-2058E584C9FFQ30454766-835C6AB6-F8FA-4A51-B895-BF9A028200AFQ30457385-BB6C58CB-73A1-45A3-9984-D48E94CFBC6EQ30464123-DFC9626E-E1DD-4287-BF2C-11FCC62323ADQ30469044-80AB97EE-EEFA-4042-BA1B-937AFFA93879Q30470074-FB23F39C-9002-460F-8801-55CE2AC536FAQ30475523-B7F7E967-B4D6-43DE-ACEC-E3BB2244E0B5Q30476813-247403F6-6CAC-498A-B495-D049A9EA4337Q30477606-C9EB41CF-0B1C-4E8E-9C4A-0BAAA8E0CB76Q30478270-6D588D03-E15A-4D86-BC43-31040DBE7314Q30479307-2DF21BAB-6197-4B71-BE51-EDB960B04731Q30484058-180095C7-CBE6-46D4-9413-C860D8D72B3DQ30486391-E11F4EB1-2D4B-4B64-8B90-2B804960E9CCQ30486395-DE3C7657-25B0-492F-9C51-E84B062BBC0CQ30488298-78430AE1-53D2-4975-9CDE-6AB5CD95CE0EQ30490689-703BA985-8423-44BF-B612-41B8881900A0Q33685348-F0A93A7D-9FC6-4457-A770-5E13DCC6B4EEQ36371481-F59EE9BA-A2FA-4B65-920A-8B205A5E8A9EQ37584398-771D1F3C-64B1-412A-AD5C-286B7FFA1B72Q37635300-756011E2-8C44-470A-8BAA-07E35F1B99F7Q38593718-19C6D4E8-001C-4B77-97F4-1ABD3F833E78Q46183471-72EDB3D3-9651-411D-8E8A-57C82B3C00AEQ48194937-F6F3842B-2EAE-48D7-B21C-6050B5F599AFQ50760353-F727D936-6C4A-4D2B-828D-574428F3A56B
P2860
Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Typical and atypical antipsych ...... of NMDA receptor hypofunction.
@ast
Typical and atypical antipsych ...... of NMDA receptor hypofunction.
@en
type
label
Typical and atypical antipsych ...... of NMDA receptor hypofunction.
@ast
Typical and atypical antipsych ...... of NMDA receptor hypofunction.
@en
prefLabel
Typical and atypical antipsych ...... of NMDA receptor hypofunction.
@ast
Typical and atypical antipsych ...... of NMDA receptor hypofunction.
@en
P2093
P2860
P1476
Typical and atypical antipsych ...... of NMDA receptor hypofunction.
@en
P2093
Beverly H Koller
Gary E Duncan
Jeffrey A Lieberman
Sheryl S Moy
P2860
P304
P356
10.1016/J.PBB.2006.09.017
P407
P577
2006-11-13T00:00:00Z